Abivax Achieves Key Milestone in Phase 3 ABTECT Trial Enrollment
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| (NASDAQ: ABVX) | Delayed: 89.49 +0.78 (0.88%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $88.71 | 52 Week High | $ | |||
| Open | $90.39 | 52 Week Low | $ | |||
| Day High | $90.87 | P/E | N/A | |||
| Day Low | $87.79 | EPS | $ | |||
| Volume | 568,111 | |||||
| (NASDAQ: ABVX) | Delayed: 89.49 +0.78 (0.88%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $88.71 | 52 Week High | $ | |||
| Open | $90.39 | 52 Week Low | $ | |||
| Day High | $90.87 | P/E | N/A | |||
| Day Low | $87.79 | EPS | $ | |||
| Volume | 568,111 | |||||
